logo
ResearchBunny Logo
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

Medicine and Health

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

F. Ren, A. Aliper, et al.

This groundbreaking research identifies TRAF2-and NCK-interacting kinase (TNIK) as an anti-fibrotic target for idiopathic pulmonary fibrosis (IPF). Utilizing artificial intelligence, the study introduces INS018_055, a small-molecule TNIK inhibitor that demonstrates significant anti-fibrotic and anti-inflammatory effects in vivo. With successful Phase I clinical trials confirming safety and tolerability, this work by esteemed authors paves the way for AI-driven advancements in drug discovery.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny